Implementation and Outreach

CAPE: Cervical Cancer Prevention in El Salvador

Cytology (pap smear) programs have not decreased mortality from cervical cancer in Low and middle income countries (LMICs). These programs are not feasible in LMICs because they require highly trained staff and a sophisticated infrastructure.

In 2012, BHI partnered with the Salvadoran Ministry of Health (MOH) to introduce low-cost HPV testing, which is potentially a more effective screening strategy in these settings. CAPE was a phased demonstration project that screened more than 28,000 women.

Analysis of this project showed that a screen and treat strategy using HPV testing was both clinically effective and less costly than conventional programs. The demonstration project was so successful that the Ministry of Health decided to use this strategy as they scaled-up cervical cancer screening and treatment nationally.

To implement this scale-up, the Salvadoran Ministry of Health (MOH) has secured one million dollars to integrate the CAPE paradigm into the public health system beginning in 2018. BHI will continue to act as a technical advisor in for this countrywide initiative.

Lastly, in collaboration with MD Anderson Cancer Center, a five-year follow-up will be conducted on the women who were screened in the CAPE project beginning in 2012, in order to find out how providing HPV testing with immediate treatment impacted the prevalence of disease in El Salvador. These interventions will help inform other programs on how to achieve an impact on the prevention of this disease.

Self - Sampling El Salvador

A total of 1,867 women performed self-sampling and over 90% of women with abnormal results received and adequate treatment.

With the support of the Rising Tide Foundation, BHI’s self-sampling research project ended in December, 2017. A total of 1,867 women performed self-sampling and over 90% of women with abnormal results received adequate treatment. This project helps to confirm that this innovative, community-based method of screening for cervical cancer offers a viable alternative to the vulnerable population of women who would not otherwise have access to care.

Haiti Screen and Treat program

A total of 1,867 women performed self-sampling and over 90% of women with abnormal results received and adequate treatment.

With the support of the Rising Tide Foundation, BHI’s self-sampling research project ended in December, 2017. A total of 1,867 women performed self-sampling and over 90% of women with abnormal results received adequate treatment. This project helps to confirm that this innovative, community-based method of screening for cervical cancer offers a viable alternative to the vulnerable population of women who would not otherwise have access to care.